Last update: Feb. 12, 2019
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
A bactericidal antibiotic from the family of 5-nitro-imidazoles. Similar in properties and action to metronidazole.
Indicated in infections from anaerobic and parasitic bacteria (Trichomonas vaginalis, Giardia intestinalis, Entamoeba histolytica).
Oral or intravenous administration in two daily doses.
Since the last update we have not found published data on its excretion in breastmilk.
Its pharmacokinetic data (low molecular weight, poor plasma protein binding) make it likely it will transfer to milk in potentially significant amounts.
Its use in newborns and infants has been proposed (Trucan 1987).
Because there are fewer published studies than for other drugs from the same group, safer known alternatives may be preferable, especially during the neonatal period and in case of prematurity.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM